QA: Soligenix INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000812796_2025_Soligenix_INC.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0000812796, Soligenix INC

  xvar xval
0 AssetsCurrent 8,828,630
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,113
3 remainder_Assets 131,740
4 LiabilitiesCurrent 4,848,412
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 231,105
8 SellingGeneralAndAdministrativeExpense 4,228,496
9 ResearchAndDevelopmentExpense 5,305,149
10 remainder_Expenses -832,180
11 remainder_Revenues 299,486
12 remainder_NetIncome 522,949
13 remainder_ComprehensiveNetIncome 17,895
  yvar yval
0 Assets 8,966,483
1 Liabilities 4,848,412
2 Expenses 8,932,570
3 Revenues 299,486
4 StockholdersEquity 4,118,071
5 NetIncome -8,110,135
6 ComprehensiveNetIncome -8,101,188
7 BaseVar 11,793,898
8 EconomicCapitalRatiobeforeLimitedLiability 0.127
9 EconomicCapitalRatio 1.54

Edgar->Model Mapping

Feature Distribution

Change over Time